Overexpression of miR-124 enhances the therapeutic benefit of TMZ treatment in the orthotopic GBM mice model by inhibition of DNA damage repair
Abstract Glioblastoma (GBM) is the most common malignant primary brain cancer with poor prognosis due to the resistant to current treatments, including the first-line drug temozolomide (TMZ). Accordingly, it is urgent to clarify the mechanism of chemotherapeutic resistance to improve the survival ra...
Saved in:
Main Authors: | Yuchen Wei, Peng Wang, Jianhui Zhao, Xin Fan, Jun Jiang, Xiuli Mu, Yuzhou Wang, Angang Yang, Rui Zhang, Shijie Hu, Zhangyan Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-01-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-025-07363-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transplantation of endothelial progenitor cells overexpressing mir‐126‐3p improves vascular repair in a diabetic rat model
by: Guangchen He, et al.
Published: (2023-04-01) -
Research of the Methylation Status of miR-124a Gene Promoter among Rheumatoid Arthritis Patients
by: Qiao Zhou, et al.
Published: (2013-01-01) -
Mesenchymal stem cell-derived extracellular vesicles enriched with miR-124 exhibit anti-inflammatory effects in collagen-induced arthritis
by: Guo Zhonghua, et al.
Published: (2024-01-01) -
Multi-omics analysis in inclusion body myositis identifies mir-16 responsible for HLA overexpression
by: Daphne Wijnbergen, et al.
Published: (2025-01-01) -
Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies
by: Tariq Javed, et al.
Published: (2012-01-01)